Europe's drug agency warns of bigger staff losses in Brexit move

Bloomberg

1 June 2018 - Regulator says it underestimated challenges of relocation.

Europe’s drug watchdog is bracing for higher-than-anticipated staff departures due to its Brexit-induced move to Amsterdam, raising pressure on the agency that oversees medication safety for about 500 million people.

A host of issues, including the effect of local labor laws on short-term contracts, could boost employee losses at the EMA beyond 19%, the level it estimated last year, Executive Director Guido Rasi said in an interview at its headquarters in London’s Canary Wharf district. Hitting that target will be “very challenging,” he said.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder